TECX Tectonic Therapeutic, Inc. - Common Stock
$35,97
Kurs · Aug 24, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$14–$40
86% of range
Analystenbewertung
BUY
16 analysts
Kursziel
$78
+116% upside
P/E (TTM)
-8.9
ROE
-27.7%
Nettogewinnmarge
—
TECX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$35.97
Marktkapitalisierung
$674M
P/E (TTM)
-8.9
EPS (TTM)
$-4.05
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-27.7%
Verschuldungsgrad
—
52W-Spanne
$14 – $40
TECX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-4.05
2021-12-31
→
2025-12-31
Freier Cashflow
$-60M
2018-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TECX
Peer-Median
P/E (TTM)
-8.9
19.6
P/B (K/B)
2.7
2.6
Price / FCF (Kurs / FCF)
-11.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TECX
Peer-Median
ROA
-35.8%
-40.3%
ROE
-27.7%
-42.4%
ROIC
-34.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TECX
Peer-Median
Current Ratio (Liquiditätsgrad)
26.6
5.4
Quick Ratio
26.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TECX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TECX
Peer-Median
TECX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
16 Analysten
- Starker Kauf 6 37,5%
- Kauf 9 56,2%
- Halten 1 6,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-22
Median
$80.00
← Unter allen Zielen
$35.97
Tief
$60.00
Hoch
$93.00
Median-Ziel
$80.00
+122,4%
Mittelwert-Ziel
$77.56
+115,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.05%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.18 | $-1.38 | 0.20% |
| 31. März 2026 | $-1.34 | $-1.21 | -0.13% |
| 31. Dezember 2025 | $-1.03 | $-1.13 | 0.10% |
| 30. September 2025 | $-1.02 | $-1.07 | 0.05% |
| 30. Juni 2025 | $-1.07 | $-1.00 | -0.07% |
| 31. März 2025 | $-0.93 | $-1.11 | 0.18% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| FTH | — | — | — | — | — | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $63M | $41M | $37M | $72M | $83M | $87M | $55M | $35M | $15M | |
| SG&A Expense | $21M | $17M | $8M | $33M | $36M | $33M | $21M | $11M | $3M | |
| Operating Expenses | $84M | $58M | $45M | $105M | $119M | $120M | $76M | $46M | $18M | |
| Operating Income | $-84M | $-58M | $-45M | $-105M | $-119M | $-120M | $-76M | $-46M | $-18M | |
| Interest Income | $11M | $4M | $581.0K | · | · | $719.0K | $3M | $2M | $57.0K | |
| Other Non-op | $-119.0K | $-511.0K | $396.0K | $-456.0K | $-285.0K | $516.0K | $3M | $-118.0K | $-262.0K | |
| Pretax Income | $-73M | $-58M | · | · | · | · | · | · | · | |
| Income Tax | $1M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | $-19M | |
| EPS (Basic) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| EPS (Diluted) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| Shares (Basic) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| Shares (Diluted) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| EBITDA | $-83M | $-56M | $11M | $-104M | $-117M | $-119M | $-75M | $-46M | · |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $254M | $141M | $29M | $93M | $190M | $260M | $187M | $126M | $6M | |
| Prepaid Expense | $3M | $6M | $2M | $7M | $10M | $8M | $9M | $4M | $345.0K | |
| Other Current Assets | · | · | $570.0K | $1M | $2M | $271.0K | $344.0K | $795.0K | $60.0K | |
| Current Assets | $257M | $147M | $31M | $100M | $199M | $267M | $196M | $130M | $6M | |
| PP&E (Net) | $1M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $349.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $7M | $8M | $5M | $5M | $3M | $394.0K | |
| Accum. Depreciation | $3M | $3M | $2M | $4M | $4M | $2M | $1M | $384.0K | $45.0K | |
| Other Non-current Assets | $640.0K | $156.0K | $31.0K | $40.0K | $74.0K | $436.0K | $625.0K | $825.0K | $365.0K | |
| Total Assets | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Accounts Payable | $1M | $976.0K | $409.0K | $384.0K | $3M | $3M | $4M | $3M | $527.0K | |
| Accrued Liabilities | $7M | $8M | $8M | $12M | $16M | $14M | $10M | $8M | $2M | |
| Current Liabilities | $10M | $12M | $41M | $13M | $19M | $17M | $14M | $11M | $3M | |
| Capital Leases | $0 | $132.0K | $2M | $188.0K | $0 | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $500.0K | |
| Total Liabilities | $10M | $12M | $43M | $29M | $34M | $17M | $15M | $11M | $4M | |
| Long-term Debt | · | · | · | $15M | $15M | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | · | |
| Paid-in Capital | $474M | $289M | $6M | · | · | · | · | · | · | |
| Retained Earnings | $-223M | $-149M | $-91M | $-489M | $-384M | $-264M | $-145M | $-72M | $-23M | |
| AOCI | $-96.0K | $9.0K | $-11.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $251M | $141M | $-85M | $-46M | $169M | $254M | $186M | $122M | $-23M | |
| Liabilities + Equity | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Shares Outstanding | 18,738,249 | 14,856,309 | 1,407,753 | 43,916,000 | 43,652,000 | 43,652,000 | 31,643,000 | 23,806,628 | 2,305,173 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $1M | $1M | $1M | $850.0K | $380.0K | $45.0K | |
| Stock-based Comp | $10M | $3M | $1M | $12M | $19M | $16M | $7M | $2M | $177.0K | |
| Deferred Tax | $19M | $17M | $15M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-16M | $-23M | $-83M | $-4M | $1M | $4M | $-2M | $6M | · | |
| Operating Cash Flow | $-60M | $-59M | $-41M | $-97M | $-98M | $-99M | $-68M | $-38M | $-16M | |
| CapEx | $208.0K | $156.0K | $279.0K | $267.0K | $2M | $1M | $2M | $2M | $383.0K | |
| Investing Cash Flow | $-138.0K | $-156.0K | $-279.0K | $-267.0K | $-2M | $-1M | $-2M | $-2M | $-383.0K | |
| Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Stock Issued | · | · | $86.0K | $204.0K | · | · | $129M | $104M | · | |
| Net Stock Activity | · | · | $86.0K | · | · | · | $129M | · | · | |
| Financing Cash Flow | $173M | $172M | $34M | $262.0K | $30M | $173M | $130M | $160M | $17M | |
| Net Change in Cash | $113M | $112M | $-7M | $-97M | $-70M | $73M | $61M | $121M | $606.0K | |
| Taxes Paid | $1M | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-60M | $-59M | $-63M | $-97M | $-100M | $-100M | $-69M | $-39M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -60.3% | 11.9% | -68.8% | -50.1% | -50.7% | -43.7% | -66.0% | · | |
| ROE | -27.7% | -39.8% | 162.5% | -122.1% | -65.6% | -51.8% | -37.1% | -35.8% | · | |
| ROIC | -34.0% | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 | 16.1 | 14.0 | 12.3 | · | |
| Quick Ratio | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 | 15.6 | 13.3 | 11.9 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | · | |
| Market Cap | $391M | $686M | $729M | $374M | $1.92B | $6.95B | $7.64B | $4.76B | · | |
| P/E | -5.2 | -6.8 | -0.5 | -3.5 | -16.6 | · | · | · | · | |
| P/B | 1.6 | 4.9 | 7.7 | 5.0 | 11.3 | 27.3 | 41.1 | 38.9 | · | |
| P / Tangible Book | 1.6 | 4.9 | · | · | 11.3 | 27.3 | · | · | · | |
| P / Cash Flow | -6.5 | -11.6 | -11.5 | -3.8 | -19.6 | -70.4 | -113.0 | -126.3 | · | |
| P / FCF | -6.5 | -11.6 | -11.5 | -3.8 | -19.1 | -69.6 | -110.4 | -120.5 | · | |
| Earnings Yield | -19.4% | -14.8% | -206.9% | -28.4% | -6.0% | · | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $21M | $16M | $17M | $17M | $13M | $9M | $14M | $7M | $11M | $3M | $8M | $9M | $17M | $18M | $16M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $2M | $-11M | $6M | $5M | $8M | $7M | $7M | |
| Operating Expenses | $24M | $27M | $22M | $22M | $22M | $18M | $14M | $20M | $11M | $13M | $-1M | $10M | $11M | $25M | $25M | $23M | |
| Operating Income | $-24M | $-27M | $-22M | $-22M | $-22M | $-18M | $-14M | $-20M | $-11M | $-13M | $1M | $-10M | $-11M | $-25M | $-25M | $-23M | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $318.0K | $256.0K | $133.0K | $97.0K | $224.0K | · | · | · | |
| Other Non-op | $-5.0K | $-113.0K | $-8.0K | $-31.0K | $-48.0K | $-32.0K | $-96.0K | $-7.0K | $-5.0K | $-403.0K | $390.0K | $-1.0K | $-8.0K | $15.0K | $-321.0K | $-95.0K | |
| Pretax Income | $-22M | · | $-19M | $-19M | $-19M | · | $-12M | $-18M | $-13M | · | · | · | · | · | · | · | |
| Income Tax | $77.0K | · | $254.0K | $0 | $976.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | |
| Net Income | $-22M | $-25M | $-19M | $-19M | $-20M | $-16M | $-12M | $-18M | $-13M | $-15M | $-8M | $-10M | $-10M | $-14M | $-25M | $-23M | |
| EPS (Basic) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| EPS (Diluted) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| Shares (Basic) | 18,964,008 | 18,769,004 | -36,227,937 | 18,712,767 | 18,680,042 | 17,157,661 | -10,546,022 | 14,729,018 | 2,919,872 | 1,387,303 | -45,316,413 | 1,319,147 | 1,228,778 | 44,037,000 | -43,773,695 | 43,773,000 | |
| Shares (Diluted) | 18,964,008 | 18,769,004 | -36,227,937 | 18,712,767 | 18,680,042 | 17,157,661 | -10,546,022 | 14,729,018 | 2,919,872 | 1,387,303 | -45,316,413 | 1,319,147 | 1,228,778 | 44,037,000 | -43,773,695 | 43,773,000 | |
| EBITDA | $-24M | $-27M | · | $-22M | $-22M | $-18M | · | $-20M | $-11M | $-8M | · | $-23M | $68M | $-25M | · | $-23M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $227M | $237M | $254M | $268M | $287M | $306M | $141M | $159M | $185M | $90M | $29M | $106M | $125M | $72M | $93M | $116M | |
| Prepaid Expense | $4M | $3M | $3M | $4M | $3M | $3M | $6M | $4M | $2M | $1M | $2M | $3M | $4M | $5M | $7M | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $626.0K | · | $805.0K | $792.0K | $845.0K | $1M | $765.0K | |
| Current Assets | $231M | $240M | $257M | $273M | $291M | $310M | $147M | $163M | $187M | $92M | $31M | $109M | $129M | $77M | $100M | $126M | |
| PP&E (Net) | $858.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | · | $3M | $0 | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | · | · | $3M | $3M | $3M | $3M | $3M | $3M | $2M | · | $2M | $4M | $4M | $4M | $4M | $3M | |
| Other Non-current Assets | $626.0K | $663.0K | $640.0K | $597.0K | $287.0K | $138.0K | $156.0K | $190.0K | $13.0K | · | $31.0K | $40.0K | $40.0K | $40.0K | $40.0K | $41.0K | |
| Total Assets | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Accounts Payable | $2M | $3M | $1M | $1M | $3M | $6M | $976.0K | $3M | $4M | $243.0K | $409.0K | $910.0K | $1M | $591.0K | $384.0K | $2M | |
| Accrued Liabilities | $7M | $9M | $7M | $7M | $7M | $5M | $8M | $13M | $20M | $3M | $8M | $5M | $8M | $11M | $12M | $14M | |
| Current Liabilities | $10M | $13M | $10M | $9M | $11M | $14M | $12M | $17M | $26M | $4M | $41M | $8M | $12M | $14M | $13M | $16M | |
| Capital Leases | $3M | $3M | $0 | $0 | $0 | $0 | $132.0K | $523.0K | $905.0K | · | $2M | $105.0K | $134.0K | $352.0K | $188.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Liabilities | $13M | $16M | $10M | $9M | $12M | $14M | $12M | $18M | $28M | $4M | $43M | $8M | $12M | $30M | $29M | $31M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | $15M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $494M | $478M | $474M | $471M | $468M | $466M | $289M | $287M | $285M | · | $6M | · | · | · | · | · | |
| Retained Earnings | $-270M | $-248M | $-223M | $-204M | $-184M | $-164M | $-149M | $-136M | $-118M | $-484M | $-91M | $-468M | $-447M | $-514M | $-489M | $-464M | |
| AOCI | $0 | $0 | $-96.0K | $-75.0K | $-49.0K | $2.0K | $9.0K | $-77.0K | $-61.0K | · | $-11.0K | · | · | · | · | · | |
| Stockholders' Equity | $224M | $230M | $251M | $268M | $284M | $301M | $141M | $150M | $166M | $89M | $-85M | $103M | $122M | $53M | $75M | $98M | |
| Liabilities + Equity | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Shares Outstanding | 19,235,221 | 18,830,436 | 18,738,249 | 18,713,223 | 18,712,138 | 18,671,229 | 14,856,309 | 14,744,477 | 14,734,323 | 44,882,000 | 1,407,753 | 44,558,000 | 44,308,000 | 44,088,000 | 43,916,000 | 43,773,000 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $285.0K | $304.0K | $333.0K | $342.0K | $340.0K | $360.0K | $508.0K | $424.0K | $713.0K | $377.0K | $373.0K | $488.0K | $289.0K | $328.0K | $351.0K | $336.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $2M | $-154.0K | $321.0K | $294.0K | $-3M | $-2M | $3M | $2M | $3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | · | $3M | · | · | · | $360.0K | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-21M | $-18M | $-14M | $-18M | $-15M | $-13M | $-17M | $-20M | $-15M | $-9M | $-12M | $6M | $-259.0K | $-20M | $-24M | $-16M | |
| CapEx | $79.0K | $19.0K | $0 | $181.0K | $0 | $27.0K | $3.0K | $153.0K | $0 | $4.0K | $50.0K | $221.0K | $214.0K | $8.0K | $0 | $86.0K | |
| Investing Cash Flow | $-59.0K | $-19.0K | $0 | $-166.0K | $55.0K | $-27.0K | $-3.0K | $-153.0K | $0 | $-4.0K | $-50.0K | $-84M | $-214.0K | $-8.0K | $0 | $-86.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $4.0K | · | $73.0K | $0 | $13.0K | $1.0K | $203.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $4.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $12M | $847.0K | $-141.0K | $-457.0K | $-4M | $178M | $-1M | $-6M | $179M | $-668.0K | $34M | $16M | $-324.0K | $55.0K | $59.0K | $60.0K | |
| Net Change in Cash | $-10M | $-17M | $-15M | $-18M | $-19M | $165M | $-18M | $-26M | $164M | $-10M | $22M | $-62M | $-797.0K | $-20M | $-24M | $-16M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-8M | · | · | · | $-20M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.4% | -9.0% | · | -8.5% | -8.2% | -7.8% | · | -12.7% | -7.7% | -7.8% | · | -18.0% | 48.2% | -19.3% | · | -13.3% | |
| ROE | -8.8% | -9.5% | · | -9.1% | -8.9% | -8.2% | · | -14.0% | -8.8% | -9.6% | · | -21.5% | 56.1% | -25.4% | · | -15.8% | |
| ROIC | -10.9% | · | · | -8.2% | -8.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 18.5 | · | 29.2 | 25.6 | 22.9 | · | 9.4 | 7.2 | 26.2 | · | 14.4 | 11.0 | 5.4 | · | 7.8 | |
| Quick Ratio | 21.9 | 18.3 | · | 28.6 | 25.3 | 22.7 | · | 9.2 | 7.1 | 25.8 | · | 14.0 | 10.7 | 5.1 | · | 7.2 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-87M | $-80M | · | $-73M | $-66M | $-62M | · | $-56M | $-48M | $-50M | · | $-58M | $-76M | $-95M | · | $-113M | |
| Market Cap | $661M | $582M | · | $294M | $372M | $331M | · | $447M | $243M | $689M | · | $823M | $505M | $529M | · | $336M | |
| P/E | -7.5 | -7.1 | · | -3.7 | -2.6 | -1.0 | · | -1.3 | -0.5 | -0.6 | · | -1.1 | -1.1 | -5.0 | · | -3.0 | |
| P/B | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Tangible Book | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Cash Flow | · | -31.6 | · | · | · | -25.3 | · | · | · | -91.1 | · | · | · | -26.1 | · | · | |
| P / FCF | · | -31.6 | · | · | · | -25.2 | · | · | · | -91.1 | · | · | · | -26.1 | · | · | |
| Earnings Yield | -13.4% | -14.1% | · | -26.9% | -38.0% | -98.5% | · | -79.6% | -190.9% | -180.1% | · | -93.2% | -89.8% | -20.1% | · | -33.7% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-74M | $-58M | $-43M | $-106M | $-119M |
| Verwässerte EPS | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 |
| Quick Ratio | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-60M | $-59M | $-63M | $-97M | $-100M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 133 Einreicher · $379.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (-2 vs. Vorquartal) | 10 (-8 vs. Vorquartal) | 34 (+2 vs. Vorquartal) | 44 (+5 vs. Vorquartal) | +124K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $58.158.512 | 1.691.884 | 15,32% | Aktien |
| TCG Crossover Management, LLC | $41.418.128 | 1.204.891 | 10,91% | Aktien |
| Aberdeen Group plc | $39.250.200 | 1.141.824 | 10,34% | Aktien |
| First Light Asset Management, LLC | $27.524.958 | 800.726 | 7,25% | Aktien |
| BAKER BROS. ADVISORS LP | $20.892.713 | 607.788 | 5,50% | Aktien |
| 5AM Venture Management, LLC | $20.853.938 | 606.660 | 5,49% | Aktien |
| BRAIDWELL LP | $20.518.438 | 596.900 | 5,40% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.802.672 | 488.805 | 4,43% | Aktien |
| Vestal Point Capital, LP | $14.609.375 | 425.000 | 3,85% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $9.700.694 | 282.202 | 2,56% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.018.537 | 233.208 | 2,11% | Aktien |
| ORBIMED ADVISORS LLC | $7.789.375 | 226.600 | 2,05% | Aktien |
| STATE STREET CORP | $7.559.338 | 219.908 | 1,99% | Aktien |
| Ikarian Capital, LLC | $7.075.647 | 205.837 | 1,86% | Aktien |
| D. E. Shaw & Co., Inc. | $6.412.656 | 186.550 | 1,69% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.054.318 | 176.100 | 1,59% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $5.689.922 | 165.525 | 1,50% | Aktien |
| Squarepoint Ops LLC | $4.985.338 | 145.028 | 1,31% | Aktien |
| AMERIPRISE FINANCIAL INC | $4.596.064 | 133.703 | 1,21% | Aktien |
| Soleus Capital Management, L.P. | $3.495.388 | 101.684 | 0,92% | Aktien |
| Woodline Partners LP | $3.437.500 | 100.000 | 0,91% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.245.481 | 94.414 | 0,85% | Aktien |
| SECTORAL ASSET MANAGEMENT INC | $2.440.934 | 71.009 | 0,64% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.351.044 | 68.394 | 0,62% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.232.313 | 64.940 | 0,59% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.089.003 | 60.771 | 0,55% | Aktien |
| KOTLER KEVIN | $1.668.800 | 80.000 | 0,44% | Aktien |
| Tetragon Partners GP Ltd | $1.598.988 | 46.516 | 0,42% | Aktien |
| PFM Health Sciences, LP | $1.568.566 | 45.631 | 0,41% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.562.344 | 45.450 | 0,41% | Aktien |
| Jump Financial, LLC | $1.491.875 | 43.400 | 0,39% | Aktien |
| Prosight Management, LP | $1.365.753 | 39.731 | 0,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.296.419 | 37.714 | 0,34% | Aktien |
| Trexquant Investment LP | $1.271.566 | 36.991 | 0,33% | Aktien |
| Aldebaran Capital, LLC | $1.264.897 | 36.797 | 0,33% | Aktien |
| ExodusPoint Capital Management, LP | $1.211.341 | 35.239 | 0,32% | Aktien |
| JANE STREET GROUP, LLC | $1.207.112 | 35.116 | 0,32% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.046.306 | 30.438 | 0,28% | Aktien |
| MONIMUS CAPITAL MANAGEMENT, LP | $967.416 | 28.143 | 0,25% | Aktien |
| ALPS ADVISORS INC | $658.178 | 19.147 | 0,17% | Aktien |
| Fisher Asset Management, LLC | $657.318 | 19.122 | 0,17% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $653.159 | 19.001 | 0,17% | Aktien |
| Quadrature Capital Ltd | $621.053 | 18.067 | 0,16% | Aktien |
| SEI INVESTMENTS CO | $585.372 | 17.029 | 0,15% | Aktien |
| CITADEL ADVISORS LLC | $584.375 | 17.000 | 0,15% | Kaufoption |
| Clearstead Advisors, LLC | $571.657 | 16.630 | 0,15% | Aktien |
| ADAR1 Capital Management, LLC | $498.472 | 14.501 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $473.439 | 13.773 | 0,12% | Aktien |
| Nuveen, LLC | $464.544 | 13.514 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $398.808 | 11.600 | 0,11% | Verkaufsoption |
| BANK OF AMERICA CORP /DE/ | $379.604 | 11.043 | 0,10% | Aktien |
| AlphaQuest LLC | $379.381 | 18.187 | 0,10% | Aktien |
| Virtus Investment Advisers, LLC | $371.456 | 10.806 | 0,10% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $358.806 | 10.438 | 0,09% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $349.250 | 10.160 | 0,09% | Aktien |
| DEUTSCHE BANK AG\ | $345.141 | 10.039 | 0,09% | Aktien |
| Brevan Howard Capital Management LP | $329.072 | 9.573 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $312.469 | 9.090 | 0,08% | Aktien |
| BARCLAYS PLC | $312.056 | 9.078 | 0,08% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $304.734 | 8.865 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $301.297 | 8.765 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $270.256 | 7.862 | 0,07% | Aktien |
| MARSHALL WACE, LLP | $258.950 | 7.532 | 0,07% | Aktien |
| JPMORGAN CHASE & CO | $254.495 | 7.691 | 0,07% | Aktien |
| AlphaCentric Advisors LLC | $238.838 | 6.948 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $231.138 | 6.724 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $230.589 | 7.460 | 0,06% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $208.313 | 6.060 | 0,05% | Aktien |
| Velan Capital Investment Management LP | $206.250 | 6.000 | 0,05% | Aktien |
| Rangeley Capital, LLC | $206.250 | 6.000 | 0,05% | Aktien |
| MORGAN STANLEY | $206.216 | 5.999 | 0,05% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $206.113 | 5.996 | 0,05% | Aktien |
| China Universal Asset Management Co., Ltd. | $189.166 | 5.503 | 0,05% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $185.625 | 5.400 | 0,05% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $183.219 | 5.330 | 0,05% | Aktien |
| Clarius Group, LLC | $179.402 | 10.130 | 0,05% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $176.894 | 5.146 | 0,05% | Aktien |
| CITIGROUP INC | $166.959 | 4.857 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $161.356 | 4.694 | 0,04% | Aktien |
| BlackRock, Inc. | $160.256 | 4.662 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $158.125 | 4.600 | 0,04% | Aktien |
| Invesco Ltd. | $143.138 | 4.164 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $90.681 | 2.638 | 0,02% | Aktien |
| VANGUARD GROUP INC | $82.689 | 3.964 | 0,02% | Aktien |
| Quantbot Technologies LP | $62.528 | 1.819 | 0,02% | Aktien |
| CWM, LLC | $56.534 | 1.829 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $52.800 | 1.536 | 0,01% | Aktien |
| Creative Planning | $46.888 | 1.364 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $38.569 | 1.122 | 0,01% | Aktien |
| US BANCORP \DE\ | $37.125 | 1.080 | 0,01% | Aktien |
| Legal & General Group Plc | $34.375 | 1.000 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $29.013 | 844 | 0,01% | Aktien |
| Chung Wu Investment Group, LLC | $27.500 | 800 | 0,01% | Aktien |
| Arax Advisory Partners | $24.922 | 725 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $22.722 | 661 | 0,01% | Aktien |
| State of Wyoming | $20.659 | 601 | 0,01% | Aktien |
| HighMark Wealth Management LLC | $20.161 | 587 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $18.391 | 595 | 0,00% | Aktien |
| Point72 (DIFC) Ltd | $17.301 | 1.103 | 0,00% | Aktien |
| SIMPLEX TRADING, LLC | $15.090 | 439 | 0,00% | Aktien |
Unternehmensinsider 33 Insider · 16 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alise Reicin | Chief Executive Officer | 20. Juni 2026 F | 310.623 | 0 | 0 | $0 |
| Erik Ostrowski | Interim CEO, President and CFO | 1. Februar 2024 M | 29.285 | 0 | 0 | $0 |
| Geoffrey Mackay | President & CEO | 8. Februar 2023 A | 188.012 | 0 | 0 | $0 |
| Daniel Lochner | Chief Financial Officer | 11. Juni 2026 A | 4.617 | 0 | 0 | $0 |
| Katina Dorton | Chief Financial Officer | 8. Oktober 2018 M | 10.000 | 0 | 0 | $0 |
| Birgitte Volck | President of R&D | 4. März 2020 A | — | 0 | 0 | $0 |
| Christian Cortis | Chief Operating Officer | 20. Juni 2024 A | 126.368 | 0 | 0 | $0 |
| Marcella K. Ruddy | Chief Medical Officer | 4. Februar 2025 A | 49.941 | 0 | 0 | $0 |
| Marc Schwabish | Chief Business Officer | 4. Februar 2025 A | 18.723 | 0 | 0 | $0 |
| Azadeh Golipour | Chief Technology Officer | 1. Februar 2024 M | 55.872 | 0 | 0 | $0 |
| Essra Ridha | Chief Medical Officer | 1. Februar 2024 M | 15.881 | 0 | 0 | $0 |
| Steven Avruch | Chief Legal Officer | 1. Februar 2024 M | 22.022 | 0 | 0 | $0 |
| Deanna M Petersen | Chief Business Officer | 8. Februar 2023 A | — | 0 | 0 | $0 |
| Christopher Mason | Chief Scientific Officer | 10. Juni 2021 A | — | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 10. Juni 2021 A | — | 0 | 0 | $0 |
| Nerissa Kreher | Chief Medical Officer | 8. Oktober 2018 M | 2.942 | 0 | 0 | $0 |
| Stefan Vitorovic | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Praveen P. Tipirneni | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Phillip B. Donenberg | Direktor | 9. Juni 2026 A | 2.000 | 0 | 0 | $0 |
| Timothy A. Springer | Direktor | 9. Juni 2026 A | 1.503.358 | 0 | 0 | $0 |
| Jessica Caroline Chutter | Direktor | 8. Juni 2026 A | — | 0 | 0 | $0 |
| Terrance McGuire | Direktor | 9. Juni 2025 A | 573.062 | 0 | 0 | $0 |
| Christopher Paige | Direktor | 6. Juni 2023 A | 252.512 | 0 | 0 | $0 |
| Annalisa Jenkins | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Philip J. Vickers | Direktor | 6. Juni 2023 A | 4.800 | 0 | 0 | $0 |
| Gail M Farfel | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Bruce Booth | Direktor | 6. Juni 2023 A | 5.567.289 | 0 | 0 | $0 |
| Ian T Clark | Direktor | 6. Juni 2023 A | — | 0 | 0 | $0 |
| Scott Requadt | Direktor | 25. Juni 2018 C | 2.962.325 | 0 | 0 | $0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10%-Eigentümer | 13. Februar 2020 J | 3.710.052 | 0 | 0 | $0 |
| Peter Mcnamara | — | 12. August 2026 M | 55.285 | 0 | 2 | $-7.525 |
| Francois Nader | — | 1. April 2026 A | — | 0 | 0 | $0 |
| Leonard Braden Michael | — | 20. Juni 2024 J | 33.333 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×5 Einreichungen | 7. April 2025 | 31,50% | Änderung | — | SEC |
| Terrance McGuire, Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Founders Capital Fund I, L.P., Polaris Founders Capital Fund Management Co. I, L.L.C., Polaris Founders Capital Fund II, L.P., Polaris Founders Capital Fund Management Co. II, L.L.C., Jonathan Flint ×3 Einreichungen | 7. April 2025 | 6,30% | Änderung | — | SEC |
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×3 Einreichungen | 7. April 2025 | 0,00% | Änderung | — | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 Einreichungen | 28. Oktober 2024 | — | Erste Einreichung | — | SEC |
| SVLSF VI, LLC, SV Life Sciences Fund VI, L.P., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. ×2 Einreichungen | 16. Februar 2021 | — | Erste Einreichung | — | SEC |
| Clarus Lifesciences III, L.P., Clarus Ventures III GP, L.P., Blackstone Clarus III L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×4 Einreichungen | 6. August 2019 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 25 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,05% | 13.966 NS | 30. April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,37% | 19.353 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,08% | 35.383 SH | 21. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 1.101 SH | 21. August 2026 | Täglich |
| BIB · ProShares Trust | 0,03% | 693 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 70.053 SH | 21. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 7.356 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 77.534 SH | 21. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 16.713 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 264.786 SH | 21. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58.897 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 4.783 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 517 NS | 31. Mai 2026 | N-PORT |
| RB · ProShares Trust | 0,01% | 3 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 404 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 19.539 SH | 21. August 2026 | Täglich |
| URTY · ProShares Trust | 0,00% | 412 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.996 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 10 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.402 SH | 21. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 111.919 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 364.413 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.713 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.002 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 25.446 SH | 19. August 2026 | Täglich |